Alexander Cumbo - Dec 2, 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Signature
/s/ David Tyronne Howton as attorney-in-fact for Alexander Cumbo
Stock symbol
SLDB
Transactions as of
Dec 2, 2022
Transactions value $
$0
Form type
4
Date filed
12/5/2022, 04:46 PM
Previous filing
Jun 13, 2022
Next filing
Jun 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Award +584 584 Dec 2, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Stock Option (Right to Buy) Award $0 +229K $0.00 229K Dec 2, 2022 Common Stock 229K $6.77 Direct F2
transaction SLDB Restricted Stock Units Award $0 +114K $0.00 114K Dec 2, 2022 Common Stock 114K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person acquired 584 shares of the issuer's common stock pursuant to the issuer's acquisition of all of the outstanding capital stock of AavantiBio, Inc. on December 2, 2022.
F2 This option was granted on December 2, 2022 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares on the first day of each calendar month thereafter until the fourth such anniversary.
F3 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").
F4 The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.